Clinical Trial

The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2023 (before its estimated April 25, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-11-14; most recent amendment 2025-05-08.
Status change: Recruiting → Completed 2025-04-03
Trial Details
NCT Number NCT05625373
Lead Sponsor Women and Infants Hospital of Rhode Island
Conditions Postoperative Complications
Enrollment 30 participants
Start Date 2022-10-25
Primary Completion 2024-04-25 (estimated)
Study Completion 2024-08-30 (estimated)
Updated on ClinicalTrials.gov 2023-12-05